Opsidio's Bridge Round

Opsidio raised a round of funding on September 25, 2017. Investors include BioAdvance.

Opsidio is a biotech company developing monoclonal antibodies to treat fibrotic and remodeling diseases.…

Articles about Opsidio's Bridge Round: